Episode Details

Back to Episodes
How Does the PreserFlo MicroShunt Stack Up Against Trabeculectomy and Other Drainage Devices?

How Does the PreserFlo MicroShunt Stack Up Against Trabeculectomy and Other Drainage Devices?

Published 5 months ago
Description

This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/how-does-the-preserflo-microshunt-stack-up-against-trabeculectomy-and-other-drainage-devices

Test your visual field online: https://visualfieldtest.com

Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support

Excerpt:

Introduction For people with open-angle glaucoma, surgical options aim to lower intraocular pressure (IOP) by creating a new drainage pathway for eye fluid (aqueous humor). The traditional gold-standard surgery is trabeculectomy, a technique that creates a small hole under a scleral flap, forming a filtering bleb under the conjunctiva. In recent years, newer implants have emerged. These include tube shunts (Ahmed, Baerveldt, Molteno implants) that channel fluid from the front of the eye to a plate under the conjunctiva, and minimally-invasive glaucoma surgeries (MIGS) such as the XEN Gel Stent and PreserFlo MicroShunt. The PreserFlo MicroShunt (formerly InnFocus MicroShunt) is a small, ab-externally implanted glaucoma device made of a soft polymer (poly(styrene-block-isobutylene-block-styrene), or SIBS). It drains fluid from the anterior chamber into a posterior subconjunctival bleb. This device is meant to be less invasive than trabeculectomy yet more effective than purely bleb-less MIGS. In this review, we compare PreserFlo to trabeculectomy and other drainage devices (Ahmed valve, Baerveldt and Molteno implants, XEN stent) in terms of how they work, clinical effectiveness, safety, practical use, and current access/cost issues. We use evidence from published trials and registries. When we report results, we note sample sizes and study years. If data are limited or mixed, we say so. Key findings are summarized in the concluding table. Background and Mechanism PreserFlo MicroShunt: The PreserFlo device is an 8.5 mm long tube with a 350 µm outer diameter and a very narrow 70 µm inner lumen (). It is made of SIBS, a biocompatible polymer that resists biodegradation (). The surgeon opens a small conjunctival/Tenon’s flap (much like for trabeculectomy) and uses mitomycin-C (an antifibrotic) under the flap. The MicroShunt is inserted ab externo: a tiny pocket is made in the sclera to accept the device fins, and a tunnel is made into the anterior chamber. The proximal tip sits inside the eye (just anterior to the iris) and the distal end drains fluid beneath the conjunctiva (see image below). Because the lumen is very small, it provides some flow resistance to help prevent severe postoperative hypotony (very low pressure). () Figure: The PreserFlo MicroShunt (red arrow) shunts aqueous humor from the anterior chamber (right) to a bleb under the conjunctiva (left) (). Trabeculectomy: In trabeculectomy, the surgeon creates a scleral flap and manually makes an opening under it (sometimes removing a small piece of iris) to connect the anterior chamber to the subconjunctival space. This creates a bleb. Mitomycin-C is often applied. Trabeculectomy is highly effective at lowering IOP, but it is invasive: it requires extensive dissection, sutures, and careful postoperative management. Tube Shunts (Ahmed, Baerveldt, Molteno): These are aqueous drainage implants. A silicone tube is inserted through the sclera into the anterior chamber. The tube drains fluid to a plate placed under the conjunctiva. The Ahmed Glaucoma Valve (AGV) includes a one-way valve designed to prevent early hypotony. The Baerveldt implant (typically 350 mm² plate) and Molteno implant (typically 275–350 mm²) are non-valved; surgeons ligate or occlude the tube temporarily to prevent imm

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us